{"brief_title": "Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer", "brief_summary": "The trial will compare the efficacy and safety of concomitant chemoradiation with tirapazamine, cisplatin and radiation versus cisplatin and radiation.", "condition": ["Head and Neck Neoplasms"], "intervention_type": ["Drug", "Drug", "Procedure"], "intervention_name": ["tirapazamine (SR259075)", "cisplatin", "Radiation Therapy"], "criteria": "Inclusion Criteria: - Previously untreated squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx. - Stage III or IV disease (excluding T1N1, and T2N1). - ECOG performance status less than or equal to 2. - Absolute neutrophil count at least 1.5 X 10^9/L, platelet count at least 100 X 10^9/L, and hemoglobin > 9g/dL. - Serum bilirubin < 1.25 times ULN and AST/ALT < 2.5 times ULN. - Calculated creatinine clearance (Cockcroft-Gault) > 55 mL/min. Exclusion Criteria: - Metastatic Disease", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "hypopharynx", "mesh_term": ["Head and Neck Neoplasms", "Tirapazamine", "Cisplatin"], "id": "NCT00094081"}